Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Caicun Zhou

Tracked across 2 events · 20 articles · First seen May 30, 2026 · Last active Sep 13, 2026

Sentiment
2
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 5
Tech
Akeso announced that a pre-specified interim analysis of overall survival (OS) in the Phase III HARMONi-2 (AK112-303) trial, assessed by the Independent Data Monitoring Committee, met the key secondary OS endpoint. Ivonescimab, Akeso's first-in-class PD-1/VEGF…
Impact: Caicun Zhou is the HARMONi-2 principal investigator and IASLC President who will deliver the formal oral presentation of the complete OS results on September 15, 2026.
Jul 20, 2026 · 6 articles
6 0
Tech
Impact: Professor Caicun Zhou presented the positive results of the OptiTROP-Lung05 study, highlighting its potential to bring new treatment options for lung cancer patients.
May 30, 2026 · 14 articles
25 Caicun Zhou delivered oral presentationIvonescimab HARMONi-2...
ERGEN INTELLIGENCE
Track Caicun Zhou live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.